Coronalvirus: NAFDAC Okays Chloroquine Production For Clinical Trials

1
193

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the production of Chloroquine for clinical trials in the search for a cure for COVID-19.

This was made known by the Director-General of the agency, Mojisola Adeyeye. He  made the announcement on today at the NAFDAC headquarters in Lagos.

She, however, pointed out that NAFDAC is not approving Chloroquine for the treatment of  COVID-19 but for clinical trials to find treatment for the virus.

READ:  White House response to coronavirus has been 'absolute chaotic disaster-Obama

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here